Cargando…
Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
PURPOSE: To explore the risk factors for thrombi occurring in patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) and establish a risk prediction model to better predict the risk of thrombosis in patients with AAV. PATIENTS AND METHODS: We retrospectively analyzed 11...
Autores principales: | Zhang, Zhihuan, Huang, Wenhan, Ren, Feifeng, Luo, Lei, Zhou, Jun, Tian, Mengxue, Wang, Zhongjie, Chen, Dandan, Tang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651082/ https://www.ncbi.nlm.nih.gov/pubmed/36389020 http://dx.doi.org/10.2147/IJGM.S384624 |
Ejemplares similares
-
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015) -
Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017) -
The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019) -
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
por: Li, Weiran, et al.
Publicado: (2021)